OTULIN and osteosarcoma: To determine whether OTULIN affects GPX4 stability associated with proteasomal degradation, osteosarcoma cells were treated with proteasome inhibitors (MG132 and PS341) and a lysosomal inhibitor (E64D) to prevent protein degradation.